Literature DB >> 18377939

Pokeweed antiviral protein region Gly209-Lys225 is critical for RNA N-glycosidase activity of the prokaryotic ribosome.

Yoshimi Nagasawa1, Kazuyuki Fujii, Takafumi Yoshikawa, Yoshinori Kobayashi, Toshiya Kondo.   

Abstract

Pokeweed antiviral protein (PAP) isolated from Phytolacca americana is a ribosome-inactivating protein (RIP) that has RNA N-glycosidase (RNG) activity towards both eukaryotic and prokaryotic ribosomes. In contrast, karasurin-A (KRN), a RIP from Trichosanthes kirilowii var. japonica, is active only on eukaryotic ribosomes. Stepwise selection of chimera proteins between PAP and KRN indicated that the C-terminal region of PAP (residues 209-225) was critical for RNG activity toward prokaryotic ribosomes. When the region of PAP (residues 209-225) was replaced with the corresponding region of KRN the PAP chimera protein, like KRN, was active only on eukaryotic ribosomes. Furthermore, insertion of the region of PAP (residues 209-225) into the KRN chimera protein resulted not only in the detectable RNG activity toward prokaryotic ribosome, but also activity toward the eukaryotic ribosomes as well that was seven-fold higher than for the original KRN. In this study, the possibility of genetic manipulation of the activity and substrate specificity of RIPs is demonstrated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18377939     DOI: 10.1016/j.phytochem.2008.02.012

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  2 in total

Review 1.  Pokeweed antiviral protein: its cytotoxicity mechanism and applications in plant disease resistance.

Authors:  Rong Di; Nilgun E Tumer
Journal:  Toxins (Basel)       Date:  2015-03-06       Impact factor: 4.546

2.  Maize ribosome-inactivating protein uses Lys158-lys161 to interact with ribosomal protein P2 and the strength of interaction is correlated to the biological activities.

Authors:  Yuen-Ting Wong; Yiu-Ming Ng; Amanda Nga-Sze Mak; Kong-Hung Sze; Kam-Bo Wong; Pang-Chui Shaw
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.